DHAKA – Bangladesh’s first homegrown Covid-19 vaccine has obtained ethical clearance for a human trial.
The Bangavax vaccine, developed by local pharmaceutical company Globe Biotech, yesterday received the clearance from the Bangladesh Medical Research Council (BMRC) after the council reviewed all documents on animal trials, according to Xinhua.
“We’ve got ethical clearance from BMRC for a human trial on up to 64 healthy adult participants,” Mohammad Mohiuddin, a senior official at Globe Biotech, told journalists.
He said BMRC informed that the company will be given clearance for widespread use if its phase-2 and phase-3 trials show the vaccine’s safety and effectiveness.
Globe Biotech applied for approval for a human trial on November 1, saying its vaccine has yielded “good results” in trials on monkeys.
The vaccine can reportedly be stored at a temperature of 4°C for one month, and -20°C for up to six months. – Bernama, November 24, 2021
